| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2005 Oxford University Press
CORRESPONDENCE |
Re: Prognostic Significance of a Short Sequence Insertion in the MCL-1 Promoter in Chronic Lymphocytic Leukemia
Affiliation of authors: Laboratory for Leukemia Diagnostics, University Hospital Grosshadern, Ludwig-Maximilians-University, Munich, Germany
Correspondence to: Frank Dicker, PhD, Laboratory for Leukemia Diagnostics, University Hospital Grosshadern, Marchioninistr. 15, 81377 Munich, Germany (e-mail: frank.dicker@med.uni-muenchen.de).
| The first 10% of the full text of this article appears below. |
High MCL-1 protein expression levels have been associated with failure to achieve complete remission in chronic lymphocytic leukemia (CLL) (1). Moshynska et al. (2) recently reported the presence of short sequence insertions, of 6 and 18 nucleotides, in the MCL-1 promoter in some CLL patients. These insertions were detected in the leukemic cell
Response to this Correspondence
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2005 97: 1093-1095.